Skip Nav Destination
Issues
1 April 2014
-
Cover Image
Cover Image
Perinatal exposure to bisphenol A (BPA) has been shown to cause aberrant mammary gland morphogenesis and mammary neoplastic transformation, though the underlying mechanism is poorly understood. Mammary glands of 21-day-old Balb/c mice were exposed to BPA by gavage (25 μg/kg/day) during puberty for 3 weeks to determine whether mammary stem cell (MaSC) function was altered leading to increased susceptibility to tumorigenesis through a stem cell– mediated mechanism. The cover art is a stylistic representation of the quantification of immunohistochemical staining patterns of FosB and c-Fos expression of regenerated ductal outgrowths in control or BPA-treated MaSCs. Pubertal exposure to the low-dose BPA increased lateral branches and hyperplasia in adultmammary glands and altered the function ofMaSC from different age groups, causing early neoplastic lesions in their regenerated glands, suggesting that MaSCs are susceptible to BPA-induced transformation. The present study is the first to show that pubertal BPA exposure altered murineMaSC gene expression and function such that they induced early neoplastic transformation. See the article by Wang and colleagues (beginning on page 445) for more information. - PDF Icon PDF LinkTable of Contents
ISSN 1940-6207
EISSN 1940-6215
Issue Sections
Obituary
Perspective
Reviews
Research Articles
Safety and Chemopreventive Effect of Polyphenon E in Preventing Early and Metastatic Progression of Prostate Cancer in TRAMP Mice
Seung Joon Kim; Ernest Amankwah; Shahnjayla Connors; Hyun Y. Park; Maria Rincon; Heather Cornnell; Ganna Chornokur; Arig Ibrahim Hashim; Junsung Choi; Ya-Yu Tsai; Robert W. Engelman; Nagi Kumar; Jong Y. Park
Letters to the Editor
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.